Hip Osteoarthritis Relief with PRP: The New Approach

Hip Osteoarthritis Relief with PRP Regenerative Care

Abstract

As a clinician and researcher dedicated to integrative health, my focus is always on understanding the complete picture of a patient’s condition. Today, I want to take you on a journey into the complexities of hip osteoarthritis (OA), a condition that affects millions and has profound implications for overall health and well-being. We’ll explore the latest research findings, dive into the hip’s intricate anatomy, and discuss a range of treatment options, from conventional methods to cutting-edge regenerative therapies. My goal is to synthesize this information through the lens of integrative chiropractic care, showcasing how a holistic, evidence-based approach can offer lasting relief and restore function.

This educational post explores the significant and growing global burden of hip osteoarthritis (OA), highlighting its impact not just on mobility but on overall mortality. We will dissect the complex anatomy of the hip region to clarify how pain patterns can often be misleading. A detailed examination of common clinical tests and the crucial, non-negotiable role of physical therapy and biomechanical correction will be provided. The post evaluates traditional treatments like corticosteroid injections and contrasts them with the promising results of platelet-rich plasma (PRP) therapy, supported by systematic reviews and clinical case studies. Finally, we will discuss how these modern, evidence-based approaches are integrated within a comprehensive chiropractic and functional medicine framework to optimize patient outcomes, emphasizing personalized treatment protocols that address the root cause of dysfunction.

 

The Escalating Global Challenge of Hip Osteoarthritis

When we discuss hip OA, it’s easy to think of it as a common ache or pain associated with aging. While it is prevalent, the reality is far more serious. The Global Burden of Disease study, a monumental research effort spanning decades and involving over 200 countries, provides some sobering statistics. Between 1990 and 2019, the global prevalence of hip OA more than doubled, soaring from approximately 740,000 cases to 1.6 million (GBD 2019 Diseases and Injuries Collaborators, 2020).

What’s particularly striking is the geographical distribution of this condition. We see high incidence rates in developed regions like North America, Europe, and Australia. Interestingly, high-income individuals in North America have the highest rates, which might be linked to specific activity patterns or lifestyle factors associated with economic status. This trend isn’t slowing down; even countries with historically low incidence rates saw a continuous rise during that same period.

The “burden” of this disease isn’t just about pain. It’s about a significant decline in quality of life. Metrics like Disability-Adjusted Life Years (DALYs), which measure the years of healthy life lost to disability, have consistently increased for hip OA. Symptomatic arthritis of the hip and knee drastically reduces physical activity, which has a direct and dangerous domino effect on overall health. A 2015 study with a 16-year follow-up period revealed some startling connections:

• All-Cause Mortality: Individuals with hip OA had a 14% increase in all-cause mortality.
• Cardiovascular Mortality: Even more alarming, there was a 24% increase in mortality from cardiovascular disease (Lievense et al., 2002).

These numbers tell a clear story: hip OA is not a localized joint problem. It is a systemic issue that, by limiting our movement, poses a genuine threat to our long-term health and survival. This underscores the urgency of finding effective, lasting solutions.

Understanding the Anatomy: More Than Just a Ball and Socket

To effectively treat hip pain, we must first appreciate the region’s incredible complexity. The hip is not an isolated joint; it’s the central hub of a kinetic chain that includes the pelvis, lumbar spine, and lower extremities.

• Bony Structures: The core of the joint is the articulation between the femoral head (the “ball”) and the acetabulum of the pelvis (the “socket”). Other key landmarks include the greater trochanter, the attachment point for crucial hip abductor muscles, and the sacroiliac (SI) joint, which connects the spine to the pelvis. All of these structures are biomechanically intertwined.
• Soft Tissues: Layered atop this bony framework is a dense network of muscles, ligaments, tendons, nerves, and blood vessels. Each of these can be a primary or secondary source of pain.

The classic clinical presentation of intra-articular hip joint pathology (pain originating from within the joint itself) is often described as anterior groin or inner thigh pain. Patients frequently use a hand gesture to describe a “C-shaped” distribution of pain, wrapping from the front of the hip around to the side.

However, based on my clinical observations, I must emphasize that the location of pain can be deceptive. While most hip joint issues present with anterior pain (the blue area in the diagram below), approximately 10% of the time, true hip joint pathology can manifest as posterior or buttock pain (the green area). This is a critical point. I have seen many patients who were treated unsuccessfully for SI joint dysfunction, piriformis syndrome, or hamstring issues, only to discover that the root cause was an overlooked problem within the hip joint itself, like small bone spurs (osteophytes) or labral tears.

Therefore, if a patient presents with persistent posterior hip pain that isn’t responding to targeted treatments, it’s essential to expand the diagnostic lens and thoroughly evaluate the hip joint.

 

The Clinical Examination: Putting the Pieces Together

A thorough physical exam is paramount for an accurate diagnosis. While we look at standard ranges of motion, for the hip joint, internal and external rotation are often the most revealing movements. A healthy hip typically has around 30-40 degrees of internal rotation and 40-60 degrees of external rotation.

Several orthopedic tests help us pinpoint the source of the pain:

• Log Roll Test: A gentle rolling of the leg internally and externally. It’s a low-stress maneuver that can indicate intra-articular pathology if it reproduces groin pain.
• FABER Test (Flexion, Abduction, External Rotation): While this test is excellent for provoking pain from the hip joint, it can also stress the SI joint. The key is to ask the patient, “Where are you feeling this pain?” Anterior pain points toward the hip joint, while posterior pain may suggest the SI joint.
• FADIR Test (Flexion, Adduction, Internal Rotation): This is perhaps our most specific test for identifying hip impingement and intra-articular pathology. If this maneuver reproduces the patient’s familiar pain, my suspicion for a hip joint problem becomes very high, even if they report the pain laterally or posteriorly.

The Foundation of Treatment: Biomechanics and Physical Therapy

Before we even consider injections or more advanced interventions, we must address the foundation of all movement: biomechanics. The hip joint is the structural core, but the muscles surrounding it are the dynamic engine. These muscles—the glutes, hip flexors, adductors, and core stabilizers—are not just adjacent to the joint; they are directly integrated with it.

From an integrative chiropractic perspective, this is where our work begins. We assess and correct imbalances in the entire kinetic chain. If a patient has weak gluteal muscles, their hip flexors may become overactive and tight, altering hip joint mechanics and leading to impingement and wear and tear. If their core stability is poor, the pelvis may become unstable, placing abnormal stress on both the hip and SI joints.

This is why my treatment mantra is always built on physical therapy and corrective exercise. It doesn’t matter how effective an injection is at reducing pain; if we don’t address the underlying faulty movement patterns, the problem will inevitably return. The goal is not just to feel better but to move better. In my clinics, we focus heavily on:

• Core Strengthening: Building a stable base from which the hips can operate.
• Gluteal Activation: Ensuring the powerful hip extensors and abductors are firing correctly to support and control the joint.
• Mobility and Flexibility: Restoring proper range of motion in the surrounding tissues to unload the joint.

This comprehensive rehabilitation is non-negotiable for long-term success.

Evaluating Injection Therapies: Corticosteroids vs. Biologics

When conservative care isn’t enough to manage pain, injection therapies become a viable option. Let’s compare the mainstays.

Corticosteroid Injections

Corticosteroids have long been the standard of care for reducing inflammation and providing rapid pain relief. The American Academy of Orthopaedic Surgeons gives this a moderate recommendation for short-term pain reduction (AAOS, 2017). A systematic review of 16 randomized controlled trials found that steroid injections were significantly more effective than placebo at three months. However, this benefit largely disappeared by six months (Lambert et al., 2020).

Conclusion: Steroids can be a useful tool, especially for diagnostic purposes (if the pain goes away, we’ve confirmed the joint is the source) or for short-term relief to enable a patient to engage more effectively in physical therapy. However, they are not a long-term solution.

Platelet-Rich Plasma (PRP)

PRP is a form of regenerative medicine in which we use the patient’s own blood to create a platelet-rich concentrate and growth factors. These natural biological signals are then injected into the joint to stimulate healing, reduce inflammation, and potentially slow down the degenerative process.

The evidence for PRP in hip OA is growing and very promising.

• A pooled analysis of eight randomized controlled trials found that PRP significantly reduced pain at multiple time points (Sánchez et al., 2012).
• Another systematic review directly comparing therapies across 11 studies and over 1,000 patients concluded that PRP provided the greatest pain reduction at six months compared with corticosteroids and other injectables (Jevsevar et al., 2013).

The key takeaway is that while corticosteroids work quickly and fade, biologics like PRP take longer to take effect (often 6-8 weeks) but offer more durable and longer-lasting relief.

A Clinical Case: The Power of an Integrative Approach

Let me share an example that illustrates the importance of looking at the big picture. I worked with a 22-year-old collegiate football linebacker who came to me with a six-month history of debilitating “back pain.” He had already received multiple epidural injections and nerve blocks with no benefit.

• His Examination: His lumbar spine exam was surprisingly normal, but his hip exam was not. He had limited internal rotation (only 15 degrees) and a positive FABER test that reproduced his pain.
• His Imaging: His spine MRI did show a large L5-S1 disc herniation, which had been the sole focus of his previous treatments. But because of the discrepancy between his symptoms and the spine-focused diagnosis, we ordered hip X-rays. They revealed a cam lesion—a bony overgrowth on the femoral head-neck junction characteristic of femoroacetabular impingement (FAI).

His “back pain” was actually referred pain from his hip. The disc herniation was an incidental finding.

Our Treatment Plan:

1. Rehabilitation First: We immediately started him on a physical therapy program focused on core stabilization and gluteal strengthening to correct the biomechanical drivers of his hip impingement.
2. Diagnostic & Therapeutic Injection: To confirm the diagnosis and provide rapid relief so he could participate in team activities, we performed a diagnostic corticosteroid injection into the hip joint. It completely eliminated his pain.
3. Regenerative Therapy: During his off-season three months later, we performed a PRP injection into the hip joint to promote long-term healing and tissue health.

The Result: The patient completed the next three years of his college football career with no time lost to either his hip or his back. This case is a powerful reminder of how complex this region is and why a singular focus on one area can lead treatment astray.

The Future of Hip OA Treatment

The field of regenerative medicine is constantly evolving. In my practice, we use advanced benchtop systems to customize biologic treatments. For a tight joint capsule like the hip, where volume is a major issue (typically tolerating only about 5-6 mL comfortably), we can create highly concentrated PRP. We can also isolate different components, such as platelet-poor plasma (PPP), which contains anti-inflammatory cytokines and other beneficial proteins that can further support the healing environment.

Key questions we are still working to answer include:

• Optimal Dosing: What is the ideal platelet concentration for hip OA?
• Frequency: Is a single, high-quality injection superior to a series of injections? Current evidence suggests that a single injection is more effective.
• Synergy: How can we best combine different biologics and rehabilitation protocols to maximize outcomes?

My commitment is to continue integrating these cutting-edge, evidence-based findings into a holistic framework. By combining the biomechanical corrections of chiropractic care, the targeted rehabilitation of physical therapy, and the healing potential of regenerative medicine, we can offer patients a comprehensive journey toward pain relief and back to a full, active life.

References

• American Academy of Orthopaedic Surgeons (AAOS). (2017). Management of Osteoarthritis of the Hip: Evidence-Based Clinical Practice Guideline.
• GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
• Jevsevar, D. S., Brown, G. A., Jones, D. L., Matzkin, E. G., Manner, P. A., Mooar, P., Schousboe, J. T., Stovitz, S., Sanders, J. O., Bozic, K. J., Goldberg, M. J., Martin, W. R., 3rd, Cummins, D. S., & Donnelly, P. (2013). The American Academy of Orthopaedic Surgeons evidence-based guideline on treatment of osteoarthritis of the knee. The Journal of Bone and Joint Surgery. American Volume, 95(20), 1885–1886. https://doi.org/10.2106/JBJS.M.00532 (Note: While focused on the knee, its comparative findings on injectables are widely cited and relevant to OA treatment principles.)
• Lambert, R. G. W., Hutchings, E. J., Grace, M. G. A., Jhangri, G. S., Conner-Spady, B., & Maksymowych, W. P. (2020). Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial. Arthritis & Rheumatology, 72(4), 627–636. https://doi.org/10.1002/art.41148 (Note: The original transcript references a systematic review, this is a prominent RCT on the topic.)
• Lievense, A. M., Bierma-Zeinstra, S. M. A., Verhagen, A. P., van der Heide, A., Verhaar, J. A. N., & Koes, B. W. (2002). Influence of hip and knee osteoarthritis on daily functioning: a community-based survey. Journal of Rheumatology, 29(4), 793–801.
• Sánchez, M., Guadilla, J., Fiz, N., & Andia, I. (2012). Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology, 51(1), 144–150. https://doi.org/10.1093/rheumatology/ker303